The estimated Net Worth of Robert S Murley is at least $730 Thousand dollars as of 14 January 2022. Mr. Murley owns over 87 units of Stericycle stock worth over $264,934 and over the last 10 years he sold SRCL stock worth over $160,400. In addition, he makes $304,960 as Independent Chairman of the Board at Stericycle.
Robert has made over 11 trades of the Stericycle stock since 2017, according to the Form 4 filled with the SEC. Most recently he exercised 87 units of SRCL stock worth $5,365 on 14 January 2022.
The largest trade he's ever made was selling 10,000 units of Stericycle stock on 9 March 2017 worth over $160,400. On average, Robert trades about 1,178 units every 53 days since 2015. As of 14 January 2022 he still owns at least 4,296 units of Stericycle stock.
You can see the complete history of Mr. Murley stock trades at the bottom of the page.
Robert S. Murley serves as Independent Chairman of the Board of the Company. Mr. Murley is a Senior Adviser to Credit Suisse, LLC, a financial services company. From 1975 to April 2012, Mr. Murley was employed by Credit Suisse, LLC and its predecessors. In 2005, he was appointed Chairman of Investment Banking in the Americas. Prior to that time, Mr. Murley headed the Global Industrial and Services Group within the Investment Banking Division, as well as the Chicago investment banking office. He was named a Managing Director in 1984 and appointed a Vice Chairman in 1998. Mr. Murley is a member of the board of directors of Health Insurance Innovations Inc., of privately held Brown Advisory Incorporated, and of the board of advisors of Harbour Group. He was formerly on the board of directors of Stone Energy Corporation and Apollo Education Group, Inc. Mr. Murley is an Emeritus Charter Trustee of Princeton University, a Trustee and the former Chairman of the Board of the Educational Testing Service in Princeton, New Jersey, is Vice Chairman of the Board of the Ann & Robert Lurie Children’s Hospital of Chicago and Chair of the Board of the Lurie Children’s Foundation, is a Trustee of the Museum of Science & Industry in Chicago, Illinois, is Chairman of the Board of the UCLA Anderson Board of Advisors.
As the Independent Chairman of the Board of Stericycle, the total compensation of Robert Murley at Stericycle is $304,960. There are 9 executives at Stericycle getting paid more, with Cindy Miller having the highest compensation of $3,215,910.
Robert Murley is 70, he's been the Independent Chairman of the Board of Stericycle since 2018. There are 1 older and 24 younger executives at Stericycle. The oldest executive at Stericycle Inc. is Veronica Hagen, 74, who is the Independent Director.
Robert's mailing address filed with the SEC is 2355 WAUKEGAN ROAD, , BANNOCKBURN, IL, 60015.
Over the last 22 years, insiders at Stericycle have traded over $161,740,081 worth of Stericycle stock and bought 27,280 units worth $1,574,920 . The most active insiders traders include Jack W Schuler, John Connaughton, and James Reid Anderson. On average, Stericycle executives and independent directors trade stock every 23 days with the average trade being worth of $835,752. The most recent stock trade was executed by Jesse Joel Jr Hackney on 16 May 2024, trading 3,620 units of SRCL stock currently worth $223,245.
stericycle is a global services company. we provide highly specialized solutions serving healthcare organizations and commercial businesses of every size and shape. throughout the last 25 years, we have grown from a small start-up in medical waste management into a leader across a range of increasingly complex and highly regulated arenas, such as: • brand protection solutions • environmental & sustainable solutions • patient & customer communication solutions • regulated waste management & compliance solutions from the start we have challenged the status quo of what a business solution can be. by identifying unmet needs, we have redefined and transformed multiple industries from a narrowly defined service category to a robust suite of solutions that customers need and want. our success with this strategy has landed stericycle among the fortune 1000 list and forbes 25 most innovative companies. a publicly-traded company with $2.5 billion in 2014 revenue, our core purpose is to
Stericycle executives and other stock owners filed with the SEC include: